ACRO BIOMEDICAL CO., LTD. financial data

Symbol
ACBM on OTC
Location
Fishers, IN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.7% % -94%
Debt-to-equity -115% %
Return On Equity 46% % 149%
Return On Assets -538% % -421%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60,042,000 shares
Common Stock, Shares, Outstanding 60,042,000 shares 0%
Common Stock, Value, Issued $60,042 USD 0%
Weighted Average Number of Shares Outstanding, Diluted 60,042,000 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Research and Development Expense $0 USD -100%
Operating Income (Loss) $147,115 USD -221%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $154,345 USD -210%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $154,345 USD -210%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $4,323 USD -99%
Operating Lease, Right-of-Use Asset $0 USD -100%
Assets $4,323 USD -89%
Liabilities, Current $436,942 USD 38%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $326,946 USD 3.6%
Retained Earnings (Accumulated Deficit) $32,801,467 USD -0.47%
Stockholders' Equity Attributable to Parent $432,619 USD -52%
Liabilities and Equity $4,323 USD -89%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,531 USD -67%
Net Cash Provided by (Used in) Financing Activities $22,306 USD 68%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 60,042,000 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,323 USD 517%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $6,871,829 USD 0.12%
Operating Lease, Liability $13,651 USD -66%
Lessee, Operating Lease, Liability, to be Paid $13,890 USD -67%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two $27,780 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $18,520 USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $239 USD -88%
Deferred Tax Assets, Operating Loss Carryforwards $6,871,829 USD 0.12%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Additional Paid in Capital $32,308,806 USD 0.02%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%